Safety Issues with Herbal Medicine
Dr. Joseph I. Boullata Pharm.D.,
Dr. Angela M. Nace Pharm.D.,
Corresponding Author
Dr. Joseph I. Boullata Pharm.D.
Department of Pharmacy Practice, Temple University School of Pharmacy, Philadelphia, Pennsylvania.
Temple University School of Pharmacy, 3307 North Broad Street, Philadelphia, PA 19140.Search for more papers by this authorDr. Angela M. Nace Pharm.D.
Drug Information Center, Temple University Hospital, Philadelphia, Pennsylvania.
Search for more papers by this author
Dr. Joseph I. Boullata Pharm.D.,
Dr. Angela M. Nace Pharm.D.,
Corresponding Author
Dr. Joseph I. Boullata Pharm.D.
Department of Pharmacy Practice, Temple University School of Pharmacy, Philadelphia, Pennsylvania.
Temple University School of Pharmacy, 3307 North Broad Street, Philadelphia, PA 19140.Search for more papers by this authorDr. Angela M. Nace Pharm.D.
Drug Information Center, Temple University Hospital, Philadelphia, Pennsylvania.
Search for more papers by this authorAbstract
As herbal medicines are used by increasing numbers of people, pharmacists must be knowledgeable about their safety. This requires appreciation of the magnitude of use, as well as regulations under which the products are marketed that may affect their safety. Unexpected effects of many popular herbal products are described in the literature. Thus the pharmacist's role in ensuring protection of the consumer continues to grow.
References
- 1 Israel, D., Youngkin, E.Q.. Herbal therapies for perimenopausal and menopausal complaints. Pharmacotherapy 1997; 17: 970–84.
- 2 Mashour, N.H., Lin, G.I., Frishman, W.H.. Herbal medicine for the treatment of cardiovascular disease: clinical considerations. Arch Intern Med 1998; 158: 2225–34.
- 3 Wong, A.H.C., Smith, M., Boon, H.S.. Herbal remedies in psychiatric practice. Arch Gen Psychiatry 1998; 55: 1033–44.
- 4 Miller, L.G.. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 1998; 158: 2200–11.
- 5 Fontanarosa, P.B., Lundberg, G.D.. Alternative medicine meets science. JAMA 1998; 28: 1618–19.
- 6 Liu, C., Douglas, R.M.. Chinese herbal medicines in the treatment of acute respiratory infections: a review of randomized and controlled clinical trials. Med J Aust 1998; 169: 579–82.
- 7 Eisenberg, D.M., Davis, R.B., Ettner, S.L., et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 1998; 280: 1569–75.
- 8 Anonymous. Dietary supplement industry growth causing fundamental cultural change. FDC Rep 1998; October 12: 4.
- 9 Kassler, W.J., Blanc, P., Greenblatt, R.. The use of medicinal herbs by human immunodeficiency virus-infected patients. Arch Intern Med 1991; 151: 2281–8.
- 10 Fairfield, K.M., Eisenberg, D.M., Davis, R.B., Libman, H., Phillips, R.S.. Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Arch Intern Med 1998; 158: 2257–64.
- 11 Kristoffersen, S.S., Atkin, P.A., Shenfield, G.M.. Uptake of alternative medicine [letter]. Lancet 1996; 347: 972.
- 12 Sugarman, J., Burk, L.. Physicians' ethical obligations regarding alternative medicine. JAMA 1998; 280: 1623–5.
- 13 Anonymous. Pharmacists' role in selling dietary supplements questioned. FDC Rep 1998; March 9: 3–5.
- 14 McCormick, E.. For one Tennessee pharmacist, herbal medicines are making a difference between profit and failure. Pharmacy Times 1997; May: 73–7.
- 15 Abdel-Rahman, S.M., Nahata, M.C.. Perspectives on alternative medicine. Ann Pharmacother 1997; 31: 1397–1400.
- 16 Davis, N.M.. Natural products and food supplements: where are our professional organizations? [editorial] Hosp Pharm 1997; 32: 1596.
- 17 Thompson, C.A.. Adverse reactions to alternative medicine [editorial]. Am J Health-Syst Pharm 1997; 54: 1707.
- 18 Krinsky, D.L.. Natural products: show me the data [editorial]. Am J Health-Syst Pharm 1998; 55: 125.
- 19 Barclay, T.S., Tsouranis, C., McCart, G.M.. Glucosamine: selecting appropriate study exclusion criteria. Ann Pharmacother 1998; 32: 1371–2.
- 20 Angell, M., Kassirer, J.P.. Alternative medicine—the risks of untested and unregulated remedies. N Engl J Med 1998; 339: 839–41.
- 21 Marsa, L.. If it's on the shelf, it's safe … right? Good Housekeeping 1998; April: 112–16, 178.
- 22 Bunten, W.. A call for self-regulation [editorial]. J Am Pharm Assoc 1999; 39: 14.
- 23 Borchers, A.T., Hackman, R.M., Keen, C.L., Stern, J.S., Gershwin, M.E.. Complementary medicine: a review of immunomodulatory effects of Chinese herbal medicines. Am J Clin Nutr 1997; 66: 1303–12.
- 24 Chan, T.Y.K.. Monitoring the safety of Chinese herbal medicines in Hong Kong. Ann Pharmacother 1996; 30: 1039–40.
- 25 Murray, L.W.. USP to reevaluate its position on botanicals. Am J Health-Syst Pharm 1998; 55: 2330–2332, 2337, 2341.
- 26 M. Blumenthal, W.R. Busse, A. Goldberg, et al, eds. The complete German commission E monographs: therapeutic guide to herbal medicines. Austin, TX: American Botanical Council, 1998.
- 27 Eliason, B.C.. Alternative medicine—the case of herbal remedies. N Engl J Med 1999; 340: 564.
- 28 Anonymous. WHO medicinal plant monographs first volume publication. FDC Rep 1998; July 27: 5–6.
- 29 DeSmet, PAGM, Brouwers, JRBJ. Pharmacokinetic evaluation of herbal remedies: basic introduction, applicability, current status and regulatory needs. Clin Pharmacokinet 1997; 32: 427–36.
- 30 United States Pharmacopeial Convention. United States pharmacopeia, 24th ed. Rockville, MD: Author, 1999.
- 31 Drew, A.K., Myers, S.P.. Safety issues in herbal medicine: implications for the health professions. Med J Aust 1997; 166: 538–41.
- 32 Anonymous. Dietary supplement AERs. FDC Rep 1998; September 7: 25.
- 33 FDA Center for Food Safety and Applied Nutrition database (updated 20 October 1998). Available at: http:vm.cfsan.fda.govdmsaems.html.
- 34 Tam, L.S., Chan, T.Y.K., Leung, W.K., Critchley, JAJH. Warfarin interactions with Chinese traditional medicines: danshen and methylsalicylate medicated oil. Aust NZ J Med 1995; 25: 258.
- 35 Oka, K., Ikeshima, K., Takahashi, N., et al. Different effects of traditional Chinese medicines containing similar herbal constituents on prednisolone pharmacokinetics. J Pharm Pharmacol 1995; 47: 687–92.
- 36 Taylor, J.R., Wilt, V.M.. Probable antagonism of warfarin by green tea. Ann Pharmacother 1999; 33: 426–8.
- 37 McRae, S.. Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng. Can Med Assoc J 1996; 155: 293–5.
- 38 Ernst, E.. Harmless herbs? A review of the recent literature. Am J Med 1998; 104: 170–8.
- 39 Janetzky, K., Morreale, A.P.. Probable interaction between warfarin and ginseng. Am J Health-Syst Pharm 1997; 54: 692–3.
- 40 Almeida, J.C., Grimsley, E.W.. Coma from the health store: interaction between kava and alprazolam. Ann Intern Med 1996; 125: 940–1.
- 41 Wasser, W.G., Feldman, N.S., D'Agati, V.D.. Chronic renal failure after ingestion of over-the-counter chromium picolinate [letter]. Ann Intern Med 1997; 126: 410.
- 42 Martin, W.R., Fuller, R.E.. Suspected chromium picolinate-induced rhabdomyolysis. Pharmacotherapy 1998; 18: 860–2.
- 43 Cerulli, J., Grabe, D.W., Gauthier, I., Malone, M., McGoldrick, M.D.. Chromium picolinate toxicity. Ann Pharmacother 1998; 32: 428–31.
- 44 DeSmet, PAGM. Health risks of herbal remedies. Drug Saf 1995; 13: 81–93.
- 45 DeSmet, PAGM, Smeets, OSNM. Potential risks of health food products containing yohimbe extracts [letter]. BMJ 1994; 309: 958.
- 46 But, P.P.H., Tomlinson, B., Cheung, K.O., et al. Adulterants of herbal products can cause poisoning [letter]. BMJ 1996; 313: 117.
- 47 Roy, A.K., Sinha, K.K., Chourasia, H.K.. Aflatoxin contamination of some drug plants. Appl Environ Microbiol 1988; 54: 842–3.
- 48 Keen, R.W., Deacon, A.C., Delves, H.T., Moreton, J.A., Frost, P.G.. Indian herbal remedies for diabetes as a cause of lead poisoning. Postgrad Med J 1994; 70: 113–14.
- 49 Dunbabin, D.W., Tallis, G.A., Popplewell, P.Y., Lee, R.A.. Lead poisoning from Indian herbal medicine (ayurveda). Med J Aust 1992; 157: 835–6.
- 50 Wu, M.S., Hong, J.J., Lin, J.L., et al. Multiple tubular dysfunction induced by mixed Chinese herbal medicines containing cadmium. Nephrol Dial Transplant 1996; 11: 867–70.
- 51 Kew, J., Morris, C., Aihie, A., et al. Arsenic and mercury intoxication due to Indian ethnic remedies. BMJ 1993; 306: 506–7.
- 52 Pye, K.G., Kelsey, S.M., House, I.M., Newland, A.C.. Severe dyserythropoiesis and autoimmune thrombocytopenia associated with ingestion of kelp supplements [letter]. Lancet 1992; 339: 1540.
- 53 Markowitz, S.B., Nunez, C.M., Klitzman, S., et al. Lead poisoning due to hai ge fen: the porphyrin content of individual erythrocytes. JAMA 1994; 271: 932–4.
- 54 Centers for Disease Control. Nonfatal arsenic poisoning in three Hmong patients—Minnesota. MMWR 1984; 33: 347–9.
- 55 Centers for Disease Control. Folk remedy-associated lead poisoning in Hmong children—Minnesota. MMWR 1988; 32: 555–6.
- 56 Slifman, N.R., Obermeyer, W.R., Musser, S.M., et al. Contamination of botanical dietary supplements by Digitalis lanata. N Engl J Med 1998; 339: 806–11.
- 57 Capobianco, D.J., Brazis, P.W., Fox, T.P.. Proximal-muscle weakness induced by herbs [letter]. N Engl J Med 1993; 329: 1430.
- 58 Hsu, C.K., Leo, P., Shastry, D., et al. Anticholinergic poisoning associated with herbal tea. Arch Intern Med 1995; 155: 2245–8.
- 59 Gertner, E., Marshall, P.S., Filandrinos, D., Potek, A.S., Smith, T.M.. Complications resulting from use of Chinese herbal medications containing undeclared prescription drugs. Arthritis Rheum 1995; 38: 614–17.
- 60 Diamond, J.R., Pallone, T.L.. Acute interstitial nephritis following use of Tung Shueh pills. Am J Kidney Dis 1994; 24: 219–21.
- 61 Abt, A.B., Oh, J.Y., Huntington, R.A., Burkhart, K.K.. Chinese herbal medicine induced acute renal failure. Arch Intern Med 1995; 155: 211–12.
- 62 Hughes, J.R., Higgins, E.M., Pembroke, A.C.. Oral dexamethasone masquerading as a Chinese herbal remedy [letter]. Br J Dermatol 1994; 130: 261.
- 63 Graham-Brown, R.A.C., Bourke, J.F., Bumphrey, G.. Chinese herbal remedies may contain steroids [letter]. BMJ 1994; 308: 473.
- 64 Stricht, Vander B.I., Parvais, O.E., Vanhaelen-Fastré, R.J., Vanhaelen, M.H.. Remedies may contain cocktail of active drugs [letter]. BMJ 1994; 308: 1162.
10.1136/bmj.308.6937.1162 Google Scholar
- 65 Centers for Disease Control and Prevention. Deaths associated with a purported aphrodisiac—New York City. MMWR 1995; 44: 853–5.
- 66 DuPont, R.L., Bogema, S.C.. Benzodiazepines in a health-catalog product [letter]. JAMA 1990; 264: 695.
- 67 Chen, Y.F., Chern, H.M., Chou, M.H., Ling, M.F.. Identification of adulteration in Chinese herbal preparations with chemical drugs and their toxicities. Ann Emerg Med 1995; 26: 717.
- 68 Huang, W.F., Wen, K.C., Hsiao, M.L.. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J Clin Pharmacol 1997; 37: 344–50.
- 69 Keane, F.M., Munn, S.E., du Vivier, W.P., Taylor, N.F., Higgins, E.M.. Analysis of Chinese herbal creams prescribed for dermatological conditions. BMJ 1999; 318: 563–4.
- 70 Larrey, D., Vial, T., Pauwels, A., et al. Hepatitis after germander (Teucrium chamedrys) administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med 1992; 117: 129–32.
- 71 Katz, M., Saibil, F.. Herbal hepatitis: subacute hepatic necrosis secondary to chaparral leaf. J Clin Gastroenterol 1990; 12: 203–6.
- 72 Centers for Disease Control and Prevention. Chaparral-induced toxic hepatitis—California and Texas, 1992. MMWR 1992; 41: 812–14.
- 73 Smith, B.C., Desmond, P.V.. Acute hepatitis induced by ingestion of the herbal medication chaparral. Aust NZ J Med 1993; 23: 526.
- 74 DeSmet, PAGM, Van Den Eertwegh, A.J.M., Stricker, BHCH. Hepatotoxicity associated with herbal tablets. BMJ 1996; 313: 92.
- 75 Melchart, D., Linde, K., Hager, S., Shaw, D., Bauer, R.. Liver enzyme elevations in patients treated with traditional Chinese medicine. JAMA 1999; 282: 28–9.
- 76 Centers for Disease Control. Diarrhea from herbal tea—New York, Pennsylvania. MMWR 1978; 27: 248–9.
- 77 Ridker, P.M.. Toxic effects of herbal teas. Arch Environ Health 1987; 42: 133–6.
- 78 Centers for Disease Control and Prevention. Anticholinergic poisoning associated with an herbal tea—New York City, 1994. MMWR 1995; 44: 193–5.
- 79 Winslow, L.C., Kroll, D.J.. Herbs as medicines. Arch Intern Med 1998; 158: 2192–9.
- 80 Chan, T.Y.K., Chan, J.C.N., Tomlinson, B., Critchley, JAJH. Chinese herbal medicines revisited: a Hong Kong perspective. Lancet 1993; 342: 1532–4.
- 81 Kane, J.A., Kane, S.P., Jain, S.. Hepatitis induced by traditional Chinese herbs; possible toxic components. Gut 1995; 36: 146–7.
- 82 Woolf, G.M., Petrovic, L.M., Rojter, S.E., et al. Acute hepatitis associated with the Chinese herbal product jin bu huan. Ann Intern Med 1994; 121: 729–35.
- 83 Bensoussan, A., Talley, N.J., Hing, M., et al. Treatment of irritable bowel syndrome with Chinese herbal medicine. JAMA 1998; 280: 1585–9.
- 84 Horowitz, R.S., Feldhaus, K., Dart, R.C., Stermitz, F.R., Beck, J.J.. The clinical spectrum of jin bu huan toxicity. Arch Intern Med 1996; 156: 899–903.
- 85 Anderson, I.B., Mullen, W.H., Meeker, J.E., et al. Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature. Ann Intern Med 1996; 124: 726–34.
- 86 Laliberté, L., Villeneuve, J.P.. Hepatitis after the use of germander, a herbal remedy. Can Med Assoc J 1996; 154: 1689–92.
- 87 Lai, R.S., Chiang, A.A., Wu, M.T., et al. Outbreak of bronchiolitis obliterans associated with consumption of Sauropus androgynus in Taiwan. Lancet 1996; 348: 83–5.
- 88 Vanherweghem, J.L., Depierreux, M., Tielemans, C., et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993; 341: 387–91.
- 89 Jadoul, M., de Plaen, J.F., Cosyns, J.P., de Strihou, C.V.Y.. Adverse effects from traditional Chinese medicine. Lancet 1993; 341: 892–3.
- 90 Siegers, C.P., von Hertzberg-Lottin, E., Schneider, B.. Anthranoid laxative abuse—a risk for colorectal cancer? Gut 1993; 34: 1099–1101.
- 91 Jones, T.K., Lawson, B.M.. Profound neonatal congestive heart failure caused by maternal consumption of blue cohosh herbal medication. J Pediatr 1998; 132: 550–2.
- 92 Grimm, W., Müller, H.H.. A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections. Am J Med 1999; 106: 138–43.
- 93 Awang, D.V.C., Dawson, B.A., Kindack, D.G., Crompton, C.W., Heptinstall, S.. Parthenolide content of feverfew (Tanacetum parthenium) assessed by HPLC and 1H-NMR spectroscopy. J Nat Prod 1991; 54: 1516–21.
- 94 Hepinstall, S.. Parthenolide content and bioactivity of feverfew: estimation of commercial and authenticated feverfew products. Pharm Pharmacol 1992; 44: 391–5.
10.1111/j.2042-7158.1992.tb03631.x Google Scholar
- 95 Lawson, L.D.. Effect of garlic on serum lipids [letter]. JAMA 1998; 280: 1568.
- 96 Bordia, A.. Effect of garlic on human platelet aggregation in vitro. Atherosclerosis 1978; 30: 355–60.
- 97 Rose, K.D., Croissant, P.D., Parliament, C.F., Levin, M.B.. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: a case report. Neurosurgery 1990; 26: 880–2.
- 98 Rosenblatt, M., Mindel, J.. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract [letter]. N Engl J Med 1997; 336: 1108.
- 99 Rowin, J., Lewis, S.L.. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 1996; 46: 1775–6.
- 100 Vale, S.. Subarachnoid haemorrhage associated with Ginkgo biloba [letter]. Lancet 1998; 352: 36.
- 101 Chong, S.K.F., Oberholzer, V.G.. Ginseng: is there a use in clinical medicine? Postgrad Med J 1988; 64: 841–6.
- 102 Dega, H., Laporte, J.L., Francès, C., Herson, S., Chosidow, O.. Ginseng as a cause for Stevens-Johnson syndrome? [letter] Lancet 1996; 347: 1344.
- 103 Ryu, S.J., Chien, Y.Y.. Ginseng-associated cerebral arteritis. Neurology 1995; 45: 829–30.
- 104 Siegel, R.K.. Ginseng abuse syndrome: problems with the panacea. JAMA 1979; 241: 1614–15.
- 105 Saxe, T.G.. Toxicity of medicinal herbal preparations. Am Fam Physician 1987; 35: 135–42.
- 106 González-Seijo, J.C., Ramos, Y.M., Lastra, I.. Manic episode and ginseng: report of a possible case. J Clin Psychopharmacol 1995; 15: 447–8.
- 107 Greenspan, E.M.. Ginseng and vaginal bleeding [letter]. JAMA 1983; 249: 2018.
- 108 Hopkins, M.P., Androff, L., Benninghoff, A.S.. Ginseng face cream and unexplained vaginal bleeding. Am J Obstet Gynecol 1988; 159: 1121–2.
- 109 Palmer, B.V., Montgomery, A.C.V., Monteiro, JCMP. Ginseng and mastalgia [letter]. Br Med J 1978; 1: 1284.
- 110 Jones, B.D., Runikis, A.M.. Interaction of ginseng with phenelzine. J Clin Psychopharmacol 1987; 7: 201–2.
- 111 Becker, B.N., Greene, J., Evanson, J., Chidsey, G., Stone, W.J.. Ginseng-induced diuretic resistance. JAMA 1998; 276: 606–7.
- 112 Liberti, L.E., Dermarderosian, A.. Evaluation of commercial ginseng products. J Pharm Sci 1978; 10: 1487–9.
- 113 Cui, J., Garle, M., Eneroth, P., et al. What do commercial ginseng preparations contain? Lancet 1994; 344: 134.
- 114 Siegel, R.K.. Kola, ginseng, and mislabeled herbs [letter]. JAMA 1977; 237: 25.
- 115 Anonymous. GNC ginseng recall. FDC Rep 1997; July 21: 30.
- 116 Anonymous. Liquid ginseng recall in Massachusetts. FDC Rep 1997; August 18: 26.
- 117 Klepser, T.B., Klepser, M.E.. Unsafe and potentially safe herbal therapies. Am J Health-Syst Pharm 1999; 56: 125–38.
- 118 Anonymous. Adverse events with ephedra and other botanical dietary supplements. FDA Med Bull 1994; 24(2): 3.
- 119 DiPaola, R.S., Zhang, H., Lambert, G.H., et al. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. N Engl J Med 1998; 339: 785–91.
- 120 Wilt, T.J., Ishani, A., Stark, G., et al. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. JAMA 1998; 280: 1604–9.
- 121 Bennett, D.A., Phun, L., Polk, J.F., et al. Neuropharmacology of St. John's wort (Hypericum). Ann Pharmacother 1998; 32: 1201–8.
- 122 Rey, J.M., Walter, G.. Hypericum perforatum (St John's wort) in depression: pest or blessing? Med J Aust 1998; 169: 583–6.
- 123 Linde, K., Ramirez, G., Mulrow, C.D., et al. St. John's wort for depression: an overview and meta-analysis of randomised clinical trials. BMJ 1996; 313: 253–8.
- 124 Bove, G.M.. Acute neuropathy after exposure to sun in a patient treated with St John's wort. Lancet 1998; 352: 1121–2.
- 125 Schneck, C.. St. John's wort and hypomania. J Clin Psychiatry 1998; 59: 689.
- 126 Anonymous. Dietary supplements marketing may be regressing to “snake oil.” FDC Rep 1998; March 9: 5–6.
- 127 Willey, L.B., Mady, S.D., Cobaugh, D.J., Wax, P.M.. Valerian overdose: a case report. Vet Hum Toxicol 1995; 37: 364–5.
- 128 Garges, H.P., Varia, I., Doraiswamy, P.M.. Cardiac complications and delirium associated with valerian root withdrawal. JAMA 1998; 280: 1566–7.
